These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 19147545

  • 1. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
    Zoubeidi A, Rocha J, Zouanat FZ, Hamel L, Scarlata E, Aprikian AG, Chevalier S.
    Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
    [Abstract] [Full Text] [Related]

  • 2. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH, Manoharan HT, Church DR, Dreckschmidt NE, Zhong W, Oberley TD, Wilding G, Verma AK.
    Cancer Res; 2007 Sep 15; 67(18):8828-38. PubMed ID: 17875724
    [Abstract] [Full Text] [Related]

  • 3. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 4. An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells.
    Aaronson DS, Muller M, Neves SR, Chung WC, Jayaram G, Iyengar R, Ram PT.
    Mol Cell Endocrinol; 2007 May 30; 270(1-2):50-6. PubMed ID: 17374439
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.
    Clin Cancer Res; 2005 Sep 01; 11(17):6333-41. PubMed ID: 16144938
    [Abstract] [Full Text] [Related]

  • 6. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.
    Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi F, Trump DL, Gao AC.
    Prostate; 2004 Sep 01; 60(4):303-9. PubMed ID: 15264241
    [Abstract] [Full Text] [Related]

  • 7. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P, Beraldi E, Ettinger S, Fazli L, Vessella RL, Nelson C, Gleave M.
    Cancer Res; 2005 Dec 01; 65(23):11083-93. PubMed ID: 16322258
    [Abstract] [Full Text] [Related]

  • 8. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
    Zhao WM, Xiu YC, Xu Y, Wang YM, Cheng ZK, Yu Q, Kong DL.
    Zhonghua Zhong Liu Za Zhi; 2007 Aug 01; 29(8):575-9. PubMed ID: 18210874
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
    Malinowska K, Neuwirt H, Cavarretta IT, Bektic J, Steiner H, Dietrich H, Moser PL, Fuchs D, Hobisch A, Culig Z.
    Endocr Relat Cancer; 2009 Mar 01; 16(1):155-69. PubMed ID: 19011039
    [Abstract] [Full Text] [Related]

  • 10. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC, DeWille JW.
    Prostate; 2005 May 01; 63(2):143-54. PubMed ID: 15486993
    [Abstract] [Full Text] [Related]

  • 11. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
    Lee SO, Dutt SS, Nadiminty N, Pinder E, Liao H, Gao AC.
    Prostate; 2007 Sep 01; 67(12):1293-300. PubMed ID: 17626246
    [Abstract] [Full Text] [Related]

  • 12. The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.
    Rocha J, Zouanat FZ, Zoubeidi A, Hamel L, Benidir T, Scarlata E, Brimo F, Aprikian A, Chevalier S.
    Mol Cell Endocrinol; 2013 Dec 05; 381(1-2):140-9. PubMed ID: 23906537
    [Abstract] [Full Text] [Related]

  • 13. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R, Huang M, Gritsko T, Karras J, Enkemann S, Mesa T, Nam S, Yu H, Jove R.
    Mol Cancer Res; 2007 Aug 05; 5(8):823-32. PubMed ID: 17699108
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC.
    Prostate; 2007 May 15; 67(7):764-73. PubMed ID: 17373716
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Bose SK, Gibson W, Giri S, Nath N, Donald CD.
    Prostate; 2009 Sep 01; 69(12):1334-42. PubMed ID: 19517575
    [Abstract] [Full Text] [Related]

  • 16. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.
    Landen CN, Lin YG, Armaiz Pena GN, Das PD, Arevalo JM, Kamat AA, Han LY, Jennings NB, Spannuth WA, Thaker PH, Lutgendorf SK, Savary CA, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK.
    Cancer Res; 2007 Nov 01; 67(21):10389-96. PubMed ID: 17974982
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
    Ni Z, Lou W, Leman ES, Gao AC.
    Cancer Res; 2000 Mar 01; 60(5):1225-8. PubMed ID: 10728680
    [Abstract] [Full Text] [Related]

  • 18. An RNA biding protein, Y14 interacts with and modulates STAT3 activation.
    Ohbayashi N, Taira N, Kawakami S, Togi S, Sato N, Ikeda O, Kamitani S, Muromoto R, Sekine Y, Matsuda T.
    Biochem Biophys Res Commun; 2008 Aug 01; 372(3):475-9. PubMed ID: 18503751
    [Abstract] [Full Text] [Related]

  • 19. Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.
    Kooijman R, Himpe E, Potikanond S, Coppens A.
    Growth Horm IGF Res; 2007 Oct 01; 17(5):383-91. PubMed ID: 17513150
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.